Category: Approval/Launch Region: Europe · Germany Company: Bayer Pharma Ag

Chinas NMPA approves Bayers larotrectinib to treat advanced solid tumours that harbour NTRK gene fusion

By, Admin 1 min read
Share
Chinas NMPA approves Bayers larotrectinib to treat advanced solid tumours that harbour NTRK gene fusion
Bayer announced that the Center of Drug Evaluation (CDE) of China

Found this useful? Share it with your team.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!

Don't Have an Account? Sign Up!